Exabis Library
Welcome to the e-CCO Library!
P298: Wall thickness ratio, a new magnetic resonance parameter, predicts the outcome of biological therapy in patients with ileal and ileocolonic Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P299 A prospective randomised trial comparing dye-based chromoendoscopy with electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P299: A novel ileocolonic Crohn’s staging tool: the development and validation of an evidence-based, end-user informed radiological decision-aid
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P299: Disability in newly diagnosed patients with Crohn´s Disease: initial results from the prospective CROCO (Crohn´s Disease Cohort) Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P299: Identification of a prognostic biomarker able to predict ulcerative colitis patients that will not respond to standard therapy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P299: Is quality of life different between Crohn’s disease patients submitted to early surgery or immunosuppression?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P299: Loss-of-response to anti-tumour necrosis factor-α critically depends on treatment duration in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P299: Prediction model for steroid-free clinical remission with vedolizumab at week 22 in patients with Ulcerative Colitis: Machine learning using clinical data at baseline
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P299: Relation of body mass index and health outcomes in elderly patients with inflammatory bowel disease (IBD)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P300 Colectomy and health-related quality life in children with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P300: Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. The STRIDENT Randomised Controlled Trial
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P300: Illness perceptions and coping with health-related quality of life in patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P300: Long-term surgical outcomes following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis in a tertiary IBD centre in Brazil
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P300: Overweight and obesity in Inflammatory Bowel disease: epidemiology, disease course and treatment outcomes
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P300: Predicting long-term outcome of ulcerative colitis using a validated histologic index of severity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P300: Predictors of a second surgery in patients with Crohn’s disease: are we following the right path?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P300: Very early onset Inflammatory Bowel Diseases: Review of the Genoa-Messina joint clinical experience. Therapeutic approach: Part II
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P301 Agreement in histologic diagnosis of preneoplastic lesions in inflammatory bowel disease: Results from a national survey in Italy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P301: A serological biomarker of type VIII collagen that contains the anti-angiogenic signalling molecule, vastatin, is associated with the extension of disease in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P301: Effects of telemonitoring on safety and health care costs with a web platform (TECCU) in complex IBD patients: A randomised controlled trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM